Friday, January 06, 2023 11:20:08 PM
skitahoe,
You know, thinking back on today’s presentation and the comment about cost by Dr. Steven Toms I think the mention of $200,000 might be the price NICE/MHRA wanted to be at before really getting on board and that probably represents the Edens manufacturing price point. A great deal of inflation to vaccine components has occurred since original estimates of cost were being made and yet today’s mention of $200,000 is kind of a retro price point. Component suppliers became an issue mentioned at the ASM too indicating that multiple approved component suppliers are needed and perhaps now they have them. So today’s price point mention looks like it could be a signal that this is where we start a more solid revenue projection analysis for NWBO from. Guessing here but at some point manufacturing agreements will need to be disclosed and Sawston would likely need to compete with at least Charles River Labs and perhaps another potential independent manufacturer unless Linda Powers and Toucan release their interest in Advent or present acceptable proof of no potential conflict of interest. Just a reminder that Charles River Labs has a location just a few miles from Advent. Best wishes.
You know, thinking back on today’s presentation and the comment about cost by Dr. Steven Toms I think the mention of $200,000 might be the price NICE/MHRA wanted to be at before really getting on board and that probably represents the Edens manufacturing price point. A great deal of inflation to vaccine components has occurred since original estimates of cost were being made and yet today’s mention of $200,000 is kind of a retro price point. Component suppliers became an issue mentioned at the ASM too indicating that multiple approved component suppliers are needed and perhaps now they have them. So today’s price point mention looks like it could be a signal that this is where we start a more solid revenue projection analysis for NWBO from. Guessing here but at some point manufacturing agreements will need to be disclosed and Sawston would likely need to compete with at least Charles River Labs and perhaps another potential independent manufacturer unless Linda Powers and Toucan release their interest in Advent or present acceptable proof of no potential conflict of interest. Just a reminder that Charles River Labs has a location just a few miles from Advent. Best wishes.
Recent NWBO News
- Form 8-K - Current report • Edgar (US Regulatory) • 04/07/2026 04:30:50 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/31/2026 09:04:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/15/2026 10:06:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2026 10:14:59 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/28/2025 09:43:27 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 11/26/2025 05:15:34 AM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/25/2025 10:23:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/20/2025 09:26:03 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 11/19/2025 09:15:48 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:44:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2025 04:29:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2025 08:40:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2025 04:28:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/14/2025 06:22:26 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2025 09:00:38 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/01/2025 09:04:38 PM
